GB814567A - Novel antibiotically active products and the production thereof - Google Patents

Novel antibiotically active products and the production thereof

Info

Publication number
GB814567A
GB814567A GB1376/57A GB137657A GB814567A GB 814567 A GB814567 A GB 814567A GB 1376/57 A GB1376/57 A GB 1376/57A GB 137657 A GB137657 A GB 137657A GB 814567 A GB814567 A GB 814567A
Authority
GB
United Kingdom
Prior art keywords
pantothenol
dihydrostreptomycin
sulphate
complex
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1376/57A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of GB814567A publication Critical patent/GB814567A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to complex compounds of streptomycin, dihydrostreptomycin, neomycin and "Viomycin" (Registered Trade Mark), or salts of these antibiotics, with pantothenol or a mono-, di-, or tri-ester thereof with an inorganic or organic acid. The complex is produced by reacting one mol. of the antibiotic with one mol. of the pantothenol or its ester. The reaction is operated preferably in the presence of a solvent or suspension means such as water. Examples describe the preparation of (a) streptomycin sulphate-pantothenol, (b) dihydrostreptomycin sulphate-pantothenol, (c) Viomycin sulphate-pantothenol, (d) neomycin sulphate-pantothenol, (e) a mixture of pantothenol and the dihydrostreptomycin sulphate-pantothenol complex, (f) a mixture of dihydrostreptomycin sulphate and the dihydrostreptomycin-sulphate pantothenol complex, (g) a mixture of dihydrostreptomycin sulphate and the dihydrostreptomycin sulphatepantothenol mono-acetic acid ester.ALSO:An antibiotic composition is produced by admixing 1 mol. of the basic antibiotic streptomycin, dihydrostreptomycin, neomycin or viomycin, or a salt of this antibiotic, with 0.5 to 3 mols. of pantothenol or a mono-, di-, or triester of pantothenol with an inorganic or organic acid. The mixtures may be prepared in the absence or presence of a solvent or suspension means such as water. The composition comprises a complex of the antibiotic with the pantothenol or ester (see Group IV (b)) with excess of one or other of the reactants. Examples disclose (a) a mixture of pantothenol and the dihydrostreptomycin sulphate pantothenol complex; (b) a mixture of dihydrostreptomycin sulphate and the dihydrostreptomycin sulphate pantothenol complex; and (c) a mixture of dihydrostreptomycin sulphate and dihydrostreptomycin sulphate pantothenol mono acetic acid ester.
GB1376/57A 1956-01-18 1957-01-14 Novel antibiotically active products and the production thereof Expired GB814567A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE814567X 1956-01-18

Publications (1)

Publication Number Publication Date
GB814567A true GB814567A (en) 1959-06-10

Family

ID=6734567

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1376/57A Expired GB814567A (en) 1956-01-18 1957-01-14 Novel antibiotically active products and the production thereof

Country Status (1)

Country Link
GB (1) GB814567A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110835309A (en) * 2019-11-28 2020-02-25 安徽泰格生物科技有限公司 Crystallization method of DL-panthenol

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110835309A (en) * 2019-11-28 2020-02-25 安徽泰格生物科技有限公司 Crystallization method of DL-panthenol

Similar Documents

Publication Publication Date Title
DE1966850A1 (en) SYNTHETIC PENICILLIN AND METHOD OF MANUFACTURING THEM EXCEPT ALPHA-SULFOBENZYLPENICILLIN
GB735408A (en) Chlorotoloxy-ethyl sulphates
GB1007769A (en) New amides, their production and pharmaceutical compositions containing them
US2585432A (en) Dibenzylamine salts of penicillin
GB814567A (en) Novel antibiotically active products and the production thereof
GB1369795A (en) Process for preparing methacrylate esters of phenol derivatives
ES8104222A1 (en) Alkylcarbapenems, their preparation, use in pharmaceutical compositions and intermediates.
JPS54103871A (en) Pseudomonic acid derivative and its preparation
GB1347598A (en) Lincomycin derivatives and the manufacture thereof
GB1338023A (en) Pyridylamino-methylenemalonates
GB1372570A (en) Synthetic penicillin and process for the preparation thereof
GB955353A (en) Improvements in or relating to novel pyridine derivatives
GB1361164A (en) Tricyclic alpha-hydroxycarboxylic acid derivatives
US2588517A (en) Biphenyl amine salts of penicillin
GB951481A (en) Improvements in or relating to antimicrobial compounds and processes for their preparation
GB975703A (en) New nitrofuran derivatives and methods of producing the same
JPS55120591A (en) Phosphinoethylmalonic acid derivative, and preparation thereof
JPS55154990A (en) Novel furanose derivative and its preparation
GB1049769A (en) Organic compounds containing an isocyclic and a heterocyclic non-aromatic ring and aprocess for the production of these compounds
JPS5630986A (en) Preparation of 7-methoxycephalosporin derivative and drug composition
ES446295A1 (en) Derivatives of salicylic acid suitable for use in therapeutics
JPS5598188A (en) Novel cephalosporin and its preparation
GB766327A (en) Penicillin salts of esters of 4-aminosalicylic acids
GB741276A (en) 3,20-diketo-11,17-dihydroxy-21-acyloxypregnanes and preparation of same
GB785141A (en) Process for the production of o,o-dimethyl phosphorothiolic acid esters